RESULTS
In the pilot study, the first participant was enrolled in November 2017; the final participant completed the study in December 2017. Of the 49 participants screened, 48 were randomized to a treatment sequence and were included in the mITT and safety populations (Figure Study flow schematic. mITT, modified intent‐to‐treat.For the efficacy study, a total of 53 participants were screened for eligibility and 48 were randomized and completed treatment (Figure 